Filing Details
- Accession Number:
- 0001264124-12-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-19 16:45:18
- Reporting Period:
- 2012-01-17
- Filing Date:
- 2012-01-19
- Accepted Time:
- 2012-01-19 16:45:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881464 | Amylin Pharmaceuticals Inc | AMLN | Pharmaceutical Preparations (2834) | 330266089 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1361754 | J Alexander Denner | 9360 Towne Centre Drive San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-01-17 | 4,889 | $0.00 | 7,889 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-01-17 | 1,104 | $0.00 | 8,993 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-01-17 | 1,832 | $11.59 | 7,161 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Phantom Stock-Deferred Compensation | Disposition | 2012-01-17 | 4,889 | $0.00 | 4,889 | $0.00 |
| Common Stock | Phantom Stock-Deferred Compensation | Disposition | 2012-01-17 | 1,104 | $0.00 | 1,104 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,104 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Represents an in-service withdrawal from Amylin's Deferred Compensation Plan pursuant to a binding election made in December 2010 at a price and on a date as determined by the provisions of the Plan.
- Each phantom stock unit was the economic equivalent of one share of Amylin Common Stock.
- Sale of common shares to satisfy reporting person's income tax withholding obligations.
Billionaire Hedge Funds
